A share price of ArriVent BioPharma Inc [AVBP] is currently trading at $24.98, up 1.17%. An important factor to consider is whether the stock is rising or falling in short-term value. The AVBP shares have gain 10.92% over the last week, with a monthly amount glided 35.83%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ArriVent BioPharma Inc [NASDAQ: AVBP] stock has seen the most recent analyst activity on November 25, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $43. On March 20, 2025, B. Riley Securities initiated with a Buy rating and assigned a price target of $37 on the stock. Guggenheim started tracking the stock assigning a Buy rating and suggested a price target of $45 on March 10, 2025. Oppenheimer initiated its recommendation with a Outperform and recommended $35 as its price target on July 22, 2024. H.C. Wainwright started tracking with a Buy rating for this stock on April 30, 2024, and assigned it a price target of $25. In a note dated February 20, 2024, Jefferies initiated an Buy rating and provided a target price of $35 on this stock.
ArriVent BioPharma Inc experienced fluctuations in its stock price throughout the past year between $15.47 and $29.86. Currently, Wall Street analysts expect the stock to reach $38 within the next 12 months. ArriVent BioPharma Inc [NASDAQ: AVBP] shares were valued at $24.98 at the most recent close of the market. An investor can expect a potential return of 52.12% based on the average AVBP price forecast.
Analyzing the AVBP fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.51, Equity is -0.55 and Total Capital is -0.59. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 24.45 points at the first support level, and at 23.91 for the second support level. However, for the 1st resistance point, the stock is sitting at 25.67, and for the 2nd resistance point, it is at 26.35.
Ratios To Look Out For
To put it in perspective, the Current Ratio for ArriVent BioPharma Inc [NASDAQ:AVBP] is 14.90. On the other hand, the Quick Ratio is 14.90, and the Cash Ratio is 5.74.
